PARTNER NEWS:Mon, Mar 4, 12:23 PM, Zacks
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why Arcturus (ARCT) steady progress with its product candidate, ARCT-032, for the treatment of cystic fibrosis is encouraging.
Fri, Mar 1, 8:55 AM, Zacks
Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts Expect? The consensus price target hints at a 32.5% upside potential for Kiniksa Pharmaceuticals, Ltd. (KNSA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Featured MNV Articles: IMTX Crosses Above Key Moving Average Level
Wednesday, May 1, 4:52 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Immatics NV (IMTX) crossed above their 200 day moving ...
KIDS Crosses Above Key Moving Average Level
Wednesday, May 1, 4:50 PM ET, by Market News Video Staff
In trading on Wednesday, shares of OrthoPediatrics Corp (KIDS) crossed above their 200 day moving ...
Notable Two Hundred Day Moving Average Cross - FTGC
Wednesday, May 1, 4:48 PM ET, by Market News Video Staff
In trading on Wednesday, shares of the First Trust Global Tactical Commodity Strategy Fund ETF ...
ATRO Makes Bullish Cross Above Critical Moving Average
Wednesday, May 1, 4:44 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Astronics Corp (ATRO) crossed above their 200 day moving ...
HBNC Crosses Above Key Moving Average Level
Wednesday, May 1, 4:41 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Horizon Bancorp Inc (HBNC) crossed above their 200 day ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|